Horn Patrick Taylor
Insider CIK 1572002 · ALBO Chief Medical Officer · TTPH Chief Medical Officer · FULC Chief Medical Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| FULC Fulcrum Therapeutics, Inc. | A Award deriv | 2024-03-18 | 2024-03-20 | 400,000 | — | $0 | 400,000 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | S Sale | 2021-10-22 | 2021-10-25 | 95 | $28.83 | $2.7K | 12,355 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | S Sale | 2021-07-22 | 2021-07-26 | 90 | $34.13 | $3.1K | 12,450 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | S Sale | 2021-04-22 | 2021-04-26 | 90 | $31.75 | $2.9K | 11,893 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | S Sale | 2021-01-22 | 2021-01-25 | 110 | $34.62 | $3.8K | 9,825 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | A Award deriv | 2021-01-21 | 2021-01-25 | 23,700 | — | $0 | 23,700 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | A Award | 2021-01-21 | 2021-01-25 | 5,500 | — | $0 | 9,935 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | S Sale | 2020-10-22 | 2020-10-23 | 89 | $34.55 | $3.1K | 4,285 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | S Sale | 2020-07-22 | 2020-07-23 | 91 | $25.80 | $2.3K | 4,374 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | S Sale | 2020-04-22 | 2020-04-24 | 92 | $17.64 | $1.6K | 4,465 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | S Sale | 2020-01-22 | 2020-01-23 | 443 | $24.29 | $10.8K | 4,557 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | A Award deriv | 2020-01-21 | 2020-01-23 | 31,500 | — | $0 | 31,500 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | A Award deriv | 2019-01-22 | 2019-01-24 | 23,000 | — | $0 | 23,000 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | A Award | 2019-01-22 | 2019-01-24 | 5,000 | — | $0 | 5,000 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | A Award deriv | 2018-08-06 | 2018-08-08 | 37,500 | — | $0 | 37,500 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | M Exercise deriv | 2017-06-13 | 2017-06-14 | 10,000 | — | $0 | 47,689 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | M Exercise | 2017-06-13 | 2017-06-14 | 10,000 | $2.03 | $20.3K | 10,000 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | A Award deriv | 2017-01-31 | 2017-02-01 | 30,000 | — | $0 | 30,000 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | A Award deriv | 2017-01-30 | 2017-02-01 | 140,000 | — | $0 | 140,000 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | A Award deriv | 2016-01-06 | 2016-01-08 | 100,000 | — | $0 | 100,000 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | A Award deriv | 2016-01-06 | 2016-01-08 | 35,000 | — | $0 | 35,000 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | M Exercise deriv | 2015-08-13 | 2015-08-17 | 10,000 | — | $0 | 57,689 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | S Sale | 2015-08-13 | 2015-08-17 | 10,000 | $44.69 | $446.9K | 0 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | M Exercise | 2015-08-13 | 2015-08-17 | 10,000 | $2.03 | $20.3K | 10,000 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | M Exercise deriv | 2015-07-13 | 2015-07-15 | 10,000 | — | $0 | 67,689 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | M Exercise | 2015-07-13 | 2015-07-15 | 10,000 | $2.03 | $20.3K | 10,000 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | S Sale | 2015-07-13 | 2015-07-15 | 10,000 | $48.93 | $489.3K | 0 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | M Exercise deriv | 2015-06-12 | 2015-06-16 | 10,000 | — | $0 | 77,689 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | M Exercise | 2015-06-12 | 2015-06-16 | 10,000 | $2.03 | $20.3K | 10,000 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | S Sale | 2015-06-12 | 2015-06-16 | 10,000 | $41.72 | $417.2K | 0 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | M Exercise deriv | 2015-05-13 | 2015-05-15 | 10,000 | — | $0 | 87,689 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | M Exercise | 2015-05-13 | 2015-05-15 | 10,000 | $2.03 | $20.3K | 10,000 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | S Sale | 2015-05-13 | 2015-05-15 | 10,000 | $39.88 | $398.8K | 0 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | A Award deriv | 2015-01-07 | 2015-01-09 | 100,000 | — | $0 | 100,000 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | A Award deriv | 2014-01-08 | 2014-01-10 | 100,000 | — | $0 | 100,000 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | A Award deriv | 2013-05-15 | 2013-05-17 | 135,000 | — | $0 | 135,000 | SEC↗ |